Uniphar (DUB:UPR) ROE % Adjusted to Book Value: 7.65% (As of Dec. 2025)

Uniphar DUB:UPR -0.65% 82 ROE % Adjusted to Book Value is 7.65% as of Dec. 2025. GuruFocus rates DUB:UPR with a GF Score™ of 82/100 and a GF Value™ of €3.64 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Uniphar's ROE % for the quarter that ended in Dec. 2025 was 17.29%. Uniphar's PB Ratio for the quarter that ended in Dec. 2025 was 2.26. Uniphar's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 7.65%.

Uniphar ROE % Adjusted to Book Value Related Terms

Uniphar ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Uniphar's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar ROE % Adjusted to Book Value Chart

Uniphar Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.90

5.77

6.52

12.14

5.61

Uniphar Semi-Annual Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROE % Adjusted to Book Value	Get a 7-Day Free Trial												8.47	4.76	18.04	3.46	7.65

DUB:UPR vs MCK, COR, CAH: ROE % Adjusted to Book Value Comparison

For the Medical Distribution subindustry, Uniphar's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Uniphar ROE % Adjusted to Book Value vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Uniphar's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Uniphar's ROE % Adjusted to Book Value falls into.

Save Embed

82GF Score

Uniphar PLC DUB:UPR

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Uniphar ROE % Adjusted to Book Value Calculation

Uniphar's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	12.67%	/	2.26
	=	5.61%

Uniphar's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	17.29%	/	2.26
	=	7.65%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 7.65% mean?

Uniphar (DUB:UPR) has a ROE % Adjusted to Book Value of 7.65% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Uniphar and its competitors.

Is Uniphar's ROE % Adjusted to Book Value too high?

Uniphar's current ROE % Adjusted to Book Value is 7.65%. Overall, Uniphar has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Uniphar's ROE % Adjusted to Book Value compare to MCK and COR?

Uniphar's ROE % Adjusted to Book Value of 7.65% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Medical Distribution company?

A good ROE % Adjusted to Book Value depends on the Medical Distribution industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Uniphar and its competitors. Uniphar's current ROE % Adjusted to Book Value is 7.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Uniphar stock overvalued right now?

Based on GuruFocus' analysis, Uniphar (DUB:UPR) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.64, compared to a current price of €4.57 — trading 25.5% above its estimated fair value. The current ROE % Adjusted to Book Value is 7.65%. Uniphar's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For Uniphar (DUB:UPR), the current ROE % Adjusted to Book Value is 7.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uniphar (DUB:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of €4.57 is trading 25.5% above its estimated GF Value™ of €3.64. GuruFocus considers Uniphar to be Modestly Overvalued.

Key valuation signals for DUB:UPR:

ROE % Adjusted to Book Value: 7.65%
GF Value™: €3.64 vs. price of €4.57 (25.5% above fair value)
GF Score™: 82/100 with 9 warning signs

No single metric tells the full story. See the DUB:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Uniphar Business Description

Industry Healthcare Medical Distribution

Comparable Companies MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP SHSE:600511 TSE:2784 SHSE:600739 NZSE:EBO TSE:9987 SHSE:600056 SZSE:000028

Other Exchanges UPR:UK 0NR:Germany

Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K

Website https://www.uniphar.ie

Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.

82GF Score

Get the complete analysis for DUB:UPR

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.57

Price

€3.64

GF Value

View DUB:UPR Analysis

See ROE % Adjusted to Book Value data for all stocks →